233 related articles for article (PubMed ID: 32385758)
1. Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies.
Hamaguchi Y; Kuwana M; Takehara K
Clin Rheumatol; 2020 Nov; 39(11):3489-3497. PubMed ID: 32385758
[TBL] [Abstract][Full Text] [Related]
2. Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera.
Cavazzana I; Fredi M; Ceribelli A; Mordenti C; Ferrari F; Carabellese N; Tincani A; Satoh M; Franceschini F
J Immunol Methods; 2016 Jun; 433():1-5. PubMed ID: 26906088
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
4. Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis.
Bonroy C; Van Praet J; Smith V; Van Steendam K; Mimori T; Deschepper E; Deforce D; Devreese K; De Keyser F
J Immunol Methods; 2012 May; 379(1-2):53-60. PubMed ID: 22446156
[TBL] [Abstract][Full Text] [Related]
5. Detection of anti-U3-RNP/fibrillarin IgG antibodies by line immunoblot assay has comparable clinical significance to immunoprecipitation testing in systemic sclerosis.
Peterson LK; Jaskowski TD; Mayes MD; Tebo AE
Immunol Res; 2016 Apr; 64(2):483-8. PubMed ID: 26467972
[TBL] [Abstract][Full Text] [Related]
6. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
[TBL] [Abstract][Full Text] [Related]
7. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
[TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosis.
Hamaguchi Y; Kuwana M; Takehara K
Int J Rheum Dis; 2019 Sep; 22(9):1746-1751. PubMed ID: 31245910
[TBL] [Abstract][Full Text] [Related]
9. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies and their clinical characteristics in systemic sclerosis].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
[TBL] [Abstract][Full Text] [Related]
11. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
12. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
Genth E; Mierau R
Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
16. Extended myositis-specific and -associated antibodies profile in systemic sclerosis: A cross-sectional study.
Leurs A; Dubucquoi S; Machuron F; Balden M; Renaud F; Rogeau S; Lopez B; Lambert M; Morell-Dubois S; Maillard H; Béhal H; Hachulla E; Launay D; Sobanski V
Joint Bone Spine; 2021 Jan; 88(1):105048. PubMed ID: 32653653
[TBL] [Abstract][Full Text] [Related]
17. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
[TBL] [Abstract][Full Text] [Related]
18. Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein properties.
Ichimura Y; Konishi R; Shobo M; Inoue S; Okune M; Maeda A; Tanaka R; Kubota N; Matsumoto I; Ishii A; Tamaoka A; Shimbo A; Mori M; Morio T; Kishi T; Miyamae T; Tanboon J; Inoue M; Nishino I; Fujimoto M; Nomura T; Okiyama N
J Dermatol; 2022 Apr; 49(4):441-447. PubMed ID: 34967032
[TBL] [Abstract][Full Text] [Related]
19. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
20. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
